T2 mapping in gadoxetic acid-enhanced MRI: utility for predicting decompensation and death in cirrhosis.

MLA

Yang, Wonjeong, et al. “T2 Mapping in Gadoxetic Acid-Enhanced MRI: Utility for Predicting Decompensation and Death in Cirrhosis.” European Radiology, vol. 31, no. 11, Nov. 2021, pp. 8376–87. EBSCOhost, https://doi.org/10.1007/s00330-021-07805-0.

APA

Yang, W., Kim, J. E., Choi, H. C., Park, M. J., Choi, H. Y., Shin, H. S., Won, J. H., Han, F., Nickel, M. D., & Cho, H. C. (2021). T2 mapping in gadoxetic acid-enhanced MRI: utility for predicting decompensation and death in cirrhosis. European Radiology, 31(11), 8376–8387. https://doi.org/10.1007/s00330-021-07805-0

Chicago

Yang, Wonjeong, Ji Eun Kim, Ho Cheol Choi, Mi Jung Park, Hye Young Choi, Hwa Seon Shin, Jeong Ho Won, Fei Han, Marcel Dominik Nickel, and Hyun Chin Cho. 2021. “T2 Mapping in Gadoxetic Acid-Enhanced MRI: Utility for Predicting Decompensation and Death in Cirrhosis.” European Radiology 31 (11): 8376–87. doi:10.1007/s00330-021-07805-0.